Valuation Becton, Dickinson and Company

Stocks

Market Closed - NYSE Other stock markets 16:00:03 2026-07-17 EDT			5-day change	1st Jan Change
158.17 ^USD	-1.10%		+4.10%	-18.50%

07-14	Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating	MT
07-14	Bactiguard lifted revenue but the operating loss widened	FW

Data adjusted to current consolidation scope

Fiscal Period: September	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	70,597	63,550	75,002	69,688	53,648	43,582	-	-
Change	-	-9.98%	18.02%	-7.08%	-23.02%	-18.76%	-	-
Enterprise Value (EV) ¹	85,924	78,609	89,465	88,081	72,188	60,096	57,540	55,820
Change	-	-8.51%	13.81%	-1.55%	-18.04%	-16.75%	-4.25%	-2.99%
P/E	35.9x	37.9x	52.3x	40.7x	32.2x	39.4x	30.4x	26.4x
PBR	2.95x	3.21x	3.71x	2.69x	2.1x	1.63x	1.6x	1.57x
PEG	-	-2.7x	-3.3x	2x	-17.36x	-1.3x	1x	1.7x
Capitalization / Revenue	3.49x	3.37x	3.87x	3.44x	2.46x	2.27x	2.21x	2.13x
EV / Revenue	4.24x	4.17x	4.62x	4.35x	3.31x	3.13x	2.92x	2.72x
EV / EBITDA	14.7x	15.2x	13.1x	12.4x	12x	10.7x	9.83x	9.08x
EV / EBIT	17.3x	18x	19.6x	18.3x	13.2x	12.5x	11.5x	10.7x
EV / FCF	25.2x	52.5x	42.3x	28.2x	27x	24.2x	18.4x	17.5x
FCF Yield	3.98%	1.91%	2.37%	3.54%	3.7%	4.13%	5.43%	5.72%
Dividend per Share ²	3.32	3.48	3.64	3.8	4.16	3.85	3.914	3.891
Rate of return	1.35%	1.56%	1.41%	1.58%	2.22%	2.43%	2.47%	2.46%
EPS ²	6.85	5.88	4.94	5.93	5.82	4.013	5.2	5.99
Distribution rate	48.5%	59.2%	73.7%	64.1%	71.5%	95.9%	75.3%	65%
Net sales ¹	20,248	18,870	19,372	20,245	21,840	19,213	19,725	20,485
EBITDA ¹	5,838	5,160	6,846	7,099	6,028	5,634	5,855	6,146
EBIT ¹	4,971	4,362	4,558	4,813	5,468	4,815	4,990	5,237
Net income ¹	2,002	1,689	1,424	1,726	1,678	1,125	1,449	1,680
Net Debt ¹	15,327	15,059	14,463	18,393	18,540	16,514	13,958	12,237
Reference price ²	245.82	222.83	258.53	241.10	187.17	158.17	158.17	158.17
Nbr of stocks (in thousands)	287,190	285,195	290,109	289,042	286,627	275,540	-	-
Announcement Date	11/4/21	11/10/22	11/9/23	11/7/24	11/6/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
BECTON, DICKINSON AND COMPANY	39.41x	3.13x	10.67x	2.43%	43.58B
ABBOTT LABORATORIES	27.38x	3.95x	15.2x	2.57%	175B
MEDTRONIC PLC	18.88x	3.31x	11.62x	3.57%	106B
CENCORA, INC.	17.13x	0.19x	12.1x	0.77%	59.91B
HOYA CORPORATION	31.81x	7.73x	20.21x	1.26%	51.95B
MEDLINE INC.	38.15x	1.39x	12.22x	0.26%	33.65B
DEXCOM, INC.	31.31x	5.58x	17.8x	-.--%	29.58B
WEST PHARMACEUTICAL SERVICES, INC.	42.57x	7.44x	26.86x	0.24%	25.31B
STERIS PLC	23.96x	3.5x	12.59x	1.21%	21.23B
SARTORIUS STEDIM BIOTECH	47.21x	6.34x	20.38x	0.46%	20.68B
Average	31.78x	4.26x	15.96x	1.28%	56.77B
Weighted average by Cap.	28.15x	3.87x	14.88x	1.94%